blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0631786

EP0631786 - Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.04.1999
Database last updated on 17.07.2024
Most recent event   Tooltip23.04.1999No opposition filed within time limitpublished on 09.06.1999 [1999/23]
Applicant(s)For all designated states
IMMUNO Aktiengesellschaft
Industriestrasse 67
A-1221 Wien / AT
[1995/01]
Inventor(s)01 / Eibl, Johann, Dr.
Gustav Tschermak-G. 2
A-1180 Wien / AT
02 / Pichler, Ludwig, Prof.
Gusshausstrasse 24
A-1040 Wien / AT
03 / Schwarz, Hans-Peter
Schindlergasse 32
A-1180 Wien / AT
[1995/01]
Representative(s)Kolb, Helga, et al
Hoffmann Eitle
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
[N/P]
Former [1995/01]Kolb, Helga, Dr. Dipl.-Chem., et al
Hoffmann, Eitle & Partner, Patent-und Rechtsanwälte, Arabellastrasse 4
D-81925 München / DE
Application number, filing date94110267.501.07.1994
[1995/01]
Priority number, dateUS1993008803302.07.1993         Original published format: US 88033
[1995/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0631786
Date:04.01.1995
Language:EN
[1995/01]
Type: B1 Patent specification 
No.:EP0631786
Date:17.06.1998
Language:EN
[1998/25]
Search report(s)(Supplementary) European search report - dispatched on:EP04.10.1994
ClassificationIPC:A61K38/48
[1995/01]
CPC:
A61K38/484 (EP,US); A61P9/00 (EP); A61P9/10 (EP)
C-Set:
A61K38/484, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   NL,   SE [1995/01]
Extension statesSI01.07.1994
TitleGerman:Lys-Plasminogen in der Verhütung und Behandlung von Ischämie und Reperfusionschäden[1995/01]
English:Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury[1995/01]
French:Lys-Plasminogen pour la prévention et le traitement de l'ischémie et les dégâts de réperfusion[1995/01]
Examination procedure02.02.1995Examination requested  [1995/13]
04.07.1996Despatch of a communication from the examining division (Time limit: M04)
28.10.1996Reply to a communication from the examining division
17.09.1997Despatch of communication of intention to grant (Approval: Yes)
03.12.1997Communication of intention to grant the patent
03.03.1998Fee for grant paid
03.03.1998Fee for publishing/printing paid
Opposition(s)18.03.1999No opposition filed within time limit [1999/23]
Fees paidRenewal fee
31.07.1996Renewal fee patent year 03
31.07.1997Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9202525  (GORDON PAUL [US]) [A] 1-37* page 1 - page 3 *;
 [Y]EP0480906  (IMMUNO AG [AT]) [Y] 4-7,14,32 * the whole document *;
 [XY]  - MEHTA, JL ET AL, "Tissue plasminogen activator and plasmin independently decrease human neutrophil activation", LIFE SCIENCES, ELMSFORD US, (1989), vol. 45, no. 18, doi:doi:10.1016/0024-3205(89)90276-2, pages 1665 - 1669, XP025525634 [X] 1-3,8-13,15-31,33-37 * the whole document * [Y] 4-7,14,32

DOI:   http://dx.doi.org/10.1016/0024-3205(89)90276-2
Examination   - Br.Med.J., vol.297, 1988, pages 1571-1574
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.